Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: The heart and soul study

American Journal of Kidney Diseases

Volumn 58, Issue 5, 2011, Pages 737-745

  Ix, Joachim H ^a,b,c   Chonchol, Michel ^d   Laughlin, Gail A ^b   Shlipak, Michael G ^e,f   Whooley, Mary A ^e,f  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

estradiol; fibroblast growth factor 23; Menopause; phosphorus; sex hormones

Indexed keywords

ESTROGEN; FIBROBLAST GROWTH FACTOR 23; PHOSPHORUS;

AGED; ARTICLE; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; EXCRETION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; PHOSPHORUS; SEX FACTORS;

EID: 80054985249     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.06.011     Document Type: Article

References (51)

1. S. Jono, M.D. McKee, and C.E. Murry Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 2000 E10 E17
2. G.A. Block, P.S. Klassen, J.M. Lazarus, N. Ofsthun, E.G. Lowrie, and G.M. Chertow Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2004 2208 2218 (Pubitemid 39031360)
3. G.M. Chertow, P. Raggi, S. Chasan-Taber, J. Bommer, H. Holzer, and S.K. Burke Determinants of progressive vascular calcification in haemodialysis patients Nephrol Dial Transplant 19 2004 1489 1496 (Pubitemid 38786743)
4. M.H. Criqui, A. Kamineni, and M.A. Allison Risk factor differences for aortic versus coronary calcified atherosclerosis: the Multiethnic Study of Atherosclerosis Arterioscler Thromb Vasc Biol 30 2010 2289 2296
5. R.N. Foley, A.J. Collins, C.A. Herzog, A. Ishani, and P.A. Kalra Serum phosphorus levels associate with coronary atherosclerosis in young adults J Am Soc Nephrol 20 2009 397 404
6. K.R. Tuttle, and R.A. Short Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function Clin J Am Soc Nephrol 4 2009 1968 1973
7. J.H. Ix, I.H. De Boer, and C.A. Peralta Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA Clin J Am Soc Nephrol 4 2009 609 615
8. J. Kendrick, J.H. Ix, G. Targher, G. Smits, and M. Chonchol Relation of serum phosphorus levels to ankle brachial pressure index (from the Third National Health and Nutrition Examination Survey) Am J Cardiol 106 2010 564 568
9. J. Meng, C.L. Wassel, and B.R. Kestenbaum Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) Study Am J Epidemiol 171 2010 909 916
10. R. Dhingra, L.M. Sullivan, and C.S. Fox Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community Arch Intern Med 167 2007 879 885 (Pubitemid 46762749)
11. R.N. Foley, A.J. Collins, A. Ishani, and P.A. Kalra Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study Am Heart J 156 2008 556 563
12. M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, and G. Curhan Relation between serum phosphate level and cardiovascular event rate in people with coronary disease Circulation 112 2005 2627 2633 (Pubitemid 41532599)
13. I.H. de Boer, T.C. Rue, and B. Kestenbaum Serum phosphorus concentrations in the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 53 2009 399 407
14. M. Cirillo, C. Ciacci, and N.G. De Santo Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults N Engl J Med 359 2008 864 866
15. S.J. Onufrak, A. Bellasi, and F. Cardarelli Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality Am J Epidemiol 169 2009 67 77
16. S. Adami, D. Gatti, and F. Bertoldo The effects of menopause and estrogen replacement therapy on the renal handling of calcium Osteoporos Int 2 1992 180 185
17. S. Faroqui, M. Levi, M. Soleimani, and H. Amlal Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia Kidney Int 73 2008 1141 1150 (Pubitemid 351620434)
18. J.L. Stock, J.A. Coderre, and L.E. Mallette Effects of a short course of estrogen on mineral metabolism in postmenopausal women J Clin Endocrinol Metab 61 1985 595 600 (Pubitemid 16248076)
19. J.L. Stock, J.A. Coderre, and J.T. Posillico Effects of estrogen on mineral metabolism in postmenopausal women as evaluated by multiple assays measuring parathyrin bioactivity Clin Chem 35 1989 18 22 (Pubitemid 19046776)
20. H. Uemura, M. Irahara, and N. Yoneda Close correlation between estrogen treatment and renal phosphate reabsorption capacity J Clin Endocrinol Metab 85 2000 1215 1219 (Pubitemid 32269375)
21. S. Liu, and L.D. Quarles How fibroblast growth factor 23 works J Am Soc Nephrol 18 2007 1637 1647 (Pubitemid 46870300)
22. B.D. Parker, L.J. Schurgers, and V.M. Brandenburg The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study Ann Intern Med 152 2010 640 648
23. T. Isakova, P. Wahl, and G.S. Vargas Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease Kidney Int 79 2011 1370 1378
24. B. Ruo, J. Rumsfeld, M. Hlatky, H. Liu, W. Browner, and M. Whooley Depressive symptoms and health-related quality of life: the Heart and Soul Study JAMA 2 2003 215 221 (Pubitemid 37430060)
25. K.B. Jonsson, R. Zahradnik, and T. Larsson Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia N Engl J Med 348 2003 1656 1663 (Pubitemid 36459471)
26. H.M. Juppner, I. Wolf, and B. Salusky FGF-23: more than a regulator of renal phosphate handling? J Bone Miner Res 25 2010 2091 2097
27. K. Wesseling-Perry, R.C. Pereira, and H. Wang Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis J Clin Endocrinol Metab 94 2009 511 517
28. D. Fliser, B. Kollerits, and U. Neyer Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study J Am Soc Nephrol 18 2007 2600 2608
29. J.H. Ix, G.M. Chertow, M.G. Shlipak, V.M. Brandenburg, M. Ketteler, and M.A. Whooley Fetuin-A and kidney function in persons with coronary artery diseasedata from the Heart and Soul Study Nephrol Dial Transplant 21 2006 2144 2151 (Pubitemid 44295038)
30. J.H. Ix, I.H. de Boer, C.L. Wassel, M.H. Criqui, M.G. Shlipak, and M.A. Whooley Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study Circulation 121 2010 1295 1303
31. J.H. Barth, R.G. Jones, and R.B. Payne Calculation of renal tubular reabsorption of phosphate: the algorithm performs better than the nomogram Ann Clin Biochem 37 pt 1 2000 79 81 (Pubitemid 30064230)
32. J.H. Ix, M.G. Shlipak, G.M. Chertow, and M.A. Whooley Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study Circulation 115 2007 173 179 (Pubitemid 46105715)
33. L.A. Stevens, J. Coresh, and C.H. Schmid Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD Am J Kidney Dis 51 2008 395 406 (Pubitemid 351273480)
34. M.D. Krailo, and M.C. Pike Estimation of the distribution of age at natural menopause from prevalence data Am J Epidemiol 117 1983 356 361 (Pubitemid 13109001)
35. I.C. Forster, N. Hernando, J. Biber, and H. Murer Proximal tubular handling of phosphate: a molecular perspective Kidney Int 70 2006 1548 1559 (Pubitemid 44606989)
36. L. Beck, A.C. Karaplis, N. Amizuka, A.S. Hewson, H. Ozawa, and H.S. Tenenhouse Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities Proc Natl Acad Sci U S A 95 1998 5372 5377 (Pubitemid 28208605)
37. H.M. Hoag, J. Martel, C. Gauthier, and H.S. Tenenhouse Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)/phosphate cotransport and cotransporter gene expression J Clin Invest 104 1999 679 686 (Pubitemid 29536353)
38. J. Meng, C. Ohlsson, and G.A. Laughlin Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men Study Kidney Int 78 2010 415 422
39. G.A. Laughlin, E. Barrett-Connor, and S. May Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study Clin Endocrinol (Oxf) 65 2006 506 513 (Pubitemid 44414275)
40. G.A. Laughlin, E. Barrett-Connor, and S. May Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones Int J Obes (Lond) 31 2007 457 465
41. R.L. Prince, I. Dick, and A. Devine The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90 J Bone Miner Res 10 1995 835 842
42. A.G. Need, P.D. O'Loughlin, H.A. Morris, M. Horowitz, and B.E. Nordin The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center J Clin Endocrinol Metab 89 2004 1646 1649 (Pubitemid 38507915)
43. N. Carrillo-Lopez, P. Roman-Garcia, A. Rodriguez-Rebollar, J.L. Fernandez-Martin, M. Naves-Diaz, and J.B. Cannata-Andia Indirect regulation of PTH by estrogens may require FGF23 J Am Soc Nephrol 20 2009 2009 2017
44. D.M. Antoniucci, T. Yamashita, and A.A. Portale Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men J Clin Endocrinol Metab 91 2006 3144 3149 (Pubitemid 44271770)
45. T. Thom, N. Haase, and W. Rosamond Heart disease and stroke statistics2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 113 2006 e85 e151
46. J.C. Gallagher, S.E. Fowler, J.R. Detter, and S.S. Sherman Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss J Clin Endocrinol Metab 86 2001 3618 3628 (Pubitemid 32755952)
47. J.C. Gallagher, B.L. Riggs, J. Eisman, A. Hamstra, S.B. Arnaud, and H.F. DeLuca Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium J Clin Invest 64 1979 729 736 (Pubitemid 10223749)
48. F. Lore, R. Nuti, A. Vattimo, and A. Caniggia Vitamin D metabolites in postmenopausal osteoporosis Horm Metab Res 16 1984 58 (Pubitemid 14224160)
49. B. Lund, O.H. Sorensen, and E. Agner Serum 1,25-dihydroxyvitamin D in normal subjects and in patients with postmenopausal osteopenia Influence of age, renal function and oestrogen therapy Horm Metab Res 14 1982 271 274 (Pubitemid 12105130)
50. M.A. Mirza, M.K. Karlsson, and D. Mellstrom Serum fibroblast growth factor-23 (FGF23) and fracture risk in elderly men J Bone Miner Res 26 2011 857 864
51. D. Hartwell, B.J. Riis, and C. Christiansen Changes in vitamin D metabolism during natural and medical menopause J Clin Endocrinol Metab 71 1990 127 132